After a 26% decline in 2025, analysts question if 2026 will be a rebound year. The company is listed among the best fundamental stocks to buy by analysts. Keefe Bruyette lowered its price target from $90 to $85 but maintained an Outperform rating, indicating continued positive long-term expectations despite the near-term target adjustment.